J. Vestbo (Odense, Denmark), A. Marcon (Verona, Italy), A. Bjerg (GöTeborg, Sweden)
Standardised mortality from chronic respiratory diseases in Russian Arctic
M. Gambaryan, A. Kalinina, A. Deev, S. Svetlana (Moscow, Russian Federation)
|  |
Measurement of COPD’s impact using the COPD assessment test (CAT) and symptom assessment differences between patients and family members
J. Fernández-Lahera, A. González Salazar, I. Lucena, A. Martínez Verdasco, C. Quero, S. Alcolea, L. Gómez, C. Prados, C. Villasante (Madrid, Spain)
| |
The Birmingham COPD cohort study – Associations between CAT, lung health and health care use
A. Dickens, P. Adab, R. Jordan, A. Enocson, J. Ayres, D. Fitzmaurice (Birmingham, United Kingdom)
|  |
The relationship between systemic inflammation and vitamin D levels in COPD
A. Kocabas, G. Derinkuyu, M. Cigerli Ocak, G. Seydaoglu, E. Ozyilmaz (Adana, Turkey)
| |
The significant relationship between ANA prevalence and male never-smokers with mixed ventilation disorders
H. Nakano, Y. Shibata, S. Inoue, A. Igarashi, K. Yamauchi, S. Abe, M. Sato, Y. Aida, H. Kishi, K. Nunomiya, T. Kayama, I. Kubota (Yamagata, Japan)
| |
Elevated serum iron as a marker for spirometric resistance to cigarette smoke: The Takahata study
Y. Shibata, S. Inoue, S. Abe, A. Igarashi, I. Kubota (Yamagata, Japan)
| |
Neutrophil gelatinase-associated lipocalin (NGAL) is associated with a reduced decline in FVC in male COPD patients
G. R. HusebØ, M. Aanerud, T. Ueland, J. A. Hardie, P. S. Bakke, T. M. Eagan (Bergen, Oslo, Norway)
| |
Influence of the seasons on exacerbation characteristics in a cohort of COPD patients (EXACO study)
A. Cortot, I. Tillie-Leblond, F. Masure, N. Roche, T. Perez, I. Boucot, F. Denis, A. Myftiu, J. Ostinelli, H. Schluep, C. Pribil, S. Schück, A. Lallemand, B. Housset (Paris, Reims, Marly Le Roi, Rueil-Malmaison, Créteil, France)
| |
Does climate change induce more heat stress related COPD exacerbations in metropolitan Berlin?
M. Hanisch, B. Parandian, U. Liebers, M. Grabenhorst, M. Jehn, C. Witt (Berlin, Germany)
| |
Comparison of gender-related risk factors for COPD – Results from the Canadian obstructive lung disease (CanCOLD) study
W. Tan, D. O'Donnell, S. Aaron, D. Marciniuk, J. M. Fitzgerald, R. Cowie, K. Chapman, P. Hernandez, D. Sin, F. Maltais, J. Bourbeau (Vancouver, Kingston, Ottawa, Saskatoon, Calgary, Toronto, Halifax, Quebec City, Montreal, Canada)
| |
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
L. Labonté, P. Mancino, W. Tan, R. Cowie, P. Hernandez, K. R. Chapman, P. Z. Li, S. Aaron, A. Benedetti, M. Fitzgerald, F. Maltais, D. Marciniuk, D. O'Donnell, D. Sin, J. Bourbeau (Montreal, Vancouver, Calgary, Halifax, Toronto, Ottawa, Québec, Saskatoon, Kingston, Canada)
| |
Incidence of chronic bronchitis: A prospective study in a large general population
M. Holm, K. Torén, E. Andersson (Göteborg, Sweden)
| |
Determinants and outcomes of physical activity in patients with COPD
E. Gimeno-Santos, A. Frei, J. de Batlle, C. Steurer-Stey, M. A. Puhan, H. Van Remoortel, T. Troosters, Y. Raste, N. S. Hopkinson, M. I. Polkey, R. A. Rabinovich, N. Karlsson, J. Garcia-Aymerich (Barcelona, Spain; Zurich, Switzerland; Leuven, Belgium; London, Edinburgh, United Kingdom; Mölndal, Sweden)
| |
Patient reported outcomes for the measurement of physical activity in COPD patients. The PROactive tools
E. Gimeno-Santos, Y. Raste, Z. Louvaris, C. de Jong, H. Demeyer, R. Rabinovich, N. Hopkinson, I. Vogiatzis, K. Kulich, D. Erzen, M. Tabberer, M. Puhan, N. Ivanoff, X. Basagaña, I. Serra, P. de Boer, F. Dobbels, T. van der Molen, M. Polkey, T. Troosters, N. Karlsson, J. Garcia-Aymerich (Barcelona, Sant Feliu de Llobregat, Spain; London, Edinburgh, Brentford, United Kingdom; Athens, Greece; Groningen, Amersfoort, Netherlands; Leuven, Belgium; Basel, Zurich, Switzerland; Ingelheim am Rhein, Germany; Mölndal, Sweden)
| |
Atrial fibrillation and stroke risk in relation to COPD and chronic productive cough
U. Nilsson, B. Johansson, B. Eriksson, A. Blomberg, B. Lundbäck, A. Lindberg (Umeå, Halmstad, Gothenburg, Luleå, Sweden)
| |
COPD subtypes at greatest risk of pneumonia: Cluster analysis
R. DiSantostefano, H. Li, D. Hinds, D. Galkin, D. Rubin (RTP, United States Of America)
| |
Birmingham COPD cohort: Comparison of characteristics of employed with non-employed patients
K. Kalirai, P. Adab, R. Jordan, D. Fitzmaurice, J. Ayres (Birmingham, United Kingdom)
| |
COPD morbidity screening in high risk groups
Y. Ivanov, A. Torossian, D. Gramatikov, D. Kostadinov, D. Osmanliev, D. Petkova, K. Kostov, O. Georgiev, V. Hodzhev, N. Kyuchukov, N. Yanev (Pleven, Plovdiv, Rousse, Sofia, Varna, Bulgaria)
| |
Symptoms of COPD in the general population are associated with overweight and obesity
B. Eriksson, A. Lindberg, E. Rönmark, B. Lundbäck (Luleå, Umeå, Gothenburg, Sweden)
| |